Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Jan 1;329(Pt 1):145–150. doi: 10.1042/bj3290145

Recombinant human sulphamidase: expression, amplification, purification and characterization.

J Bielicki 1, J J Hopwood 1, E L Melville 1, D S Anson 1
PMCID: PMC1219025  PMID: 9405287

Abstract

Mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo A syndrome) is a lysosomal storage disease that causes a profound neurological deterioration. The disorder is caused by a deficiency of the lysosomal enzyme sulphamidase which is a requisite for the degradation of heparan sulphate. To facilitate the development of enzyme-replacement strategies for MPS IIIA patients, we have constructed a high-level expression system for recombinant human sulphamidase in Chinese hamster ovary (CHO) cells. An expression construct containing a methotrexate-resistant dihydrofolate reductase (DHFR) gene allowed amplification of expression levels from less than 1 mg of sulphamidase per litre of culture medium to approx. 15 mg/l. Unlike many cell lines made by gene amplification in DHFR-deficient CHO cells, and utilizing the normal DHFR gene, these cell lines appeared to be stable in the absence of selective pressure. Recombinant human sulphamidase was purified from unamplified and amplified cell lines. The native enzyme was found to be a dimer of 115 kDa. Denaturing and reducing SDS/PAGE revealed a subunit size of 62 kDa. Kinetic analysis demonstrated that the recombinant enzyme had broadly similar kinetic characteristics to sulphamidase purified from liver. Recombinant human sulphamidase was able to correct the storage phenotype of MPS IIIA fibroblasts after endocytosis via the mannose-6-phosphate receptor.

Full Text

The Full Text of this article is available as a PDF (247.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anson D. S., Taylor J. A., Bielicki J., Harper G. S., Peters C., Gibson G. J., Hopwood J. J. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J. 1992 Jun 15;284(Pt 3):789–794. doi: 10.1042/bj2840789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bielicki J., Freeman C., Clements P. R., Hopwood J. J. Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties. Biochem J. 1990 Oct 1;271(1):75–86. doi: 10.1042/bj2710075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bielicki J., Fuller M., Guo X. H., Morris C. P., Hopewood J. J., Anson D. S. Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase. Biochem J. 1995 Oct 1;311(Pt 1):333–339. doi: 10.1042/bj3110333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bielicki J., Hopwood J. J., Anson D. S. Correction of Sanfilippo A skin fibroblasts by retroviral vector-mediated gene transfer. Hum Gene Ther. 1996 Oct 20;7(16):1965–1970. doi: 10.1089/hum.1996.7.16-1965. [DOI] [PubMed] [Google Scholar]
  5. Bielicki J., Hopwood J. J., Wilson P. J., Anson D. S. Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem J. 1993 Jan 1;289(Pt 1):241–246. doi: 10.1042/bj2890241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Freeman C., Hopwood J. J. Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties. Biochem J. 1986 Feb 15;234(1):83–92. doi: 10.1042/bj2340083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Friden P. M., Walus L. R., Musso G. F., Taylor M. A., Malfroy B., Starzyk R. M. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4771–4775. doi: 10.1073/pnas.88.11.4771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fukuta M., Okada H., Iinuma S., Yanai S., Toguchi H. Insulin fragments as a carrier for peptide delivery across the blood-brain barrier. Pharm Res. 1994 Dec;11(12):1681–1688. doi: 10.1023/a:1018942728317. [DOI] [PubMed] [Google Scholar]
  9. Ioannou Y. A., Bishop D. F., Desnick R. J. Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion. J Cell Biol. 1992 Dec;119(5):1137–1150. doi: 10.1083/jcb.119.5.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karageorgos L. E., Guo X. H., Blanch L., Weber B., Anson D. S., Scott H. S., Hopwood J. J. Structure and sequence of the human sulphamidase gene. DNA Res. 1996 Aug 31;3(4):269–271. doi: 10.1093/dnares/3.4.269. [DOI] [PubMed] [Google Scholar]
  11. LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Litjens T., Bielicki J., Anson D. S., Friderici K., Jones M. Z., Hopwood J. J. Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase. Biochem J. 1997 Oct 1;327(Pt 1):89–94. doi: 10.1042/bj3270089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Meikle P. J., Brooks D. A., Ravenscroft E. M., Yan M., Williams R. E., Jaunzems A. E., Chataway T. K., Karageorgos L. E., Davey R. C., Boulter C. D. Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin Chem. 1997 Aug;43(8 Pt 1):1325–1335. [PubMed] [Google Scholar]
  16. Poduslo J. F., Curran G. L. Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers. J Neurochem. 1996 Apr;66(4):1599–1609. doi: 10.1046/j.1471-4159.1996.66041599.x. [DOI] [PubMed] [Google Scholar]
  17. Scott H. S., Blanch L., Guo X. H., Freeman C., Orsborn A., Baker E., Sutherland G. R., Morris C. P., Hopwood J. J. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Nat Genet. 1995 Dec;11(4):465–467. doi: 10.1038/ng1295-465. [DOI] [PubMed] [Google Scholar]
  18. Simonsen C. C., Levinson A. D. Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc Natl Acad Sci U S A. 1983 May;80(9):2495–2499. doi: 10.1073/pnas.80.9.2495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Van Hove J. L., Yang H. W., Wu J. Y., Brady R. O., Chen Y. T. High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):65–70. doi: 10.1073/pnas.93.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Whiteman P., Young E. The laboratory diagnosis of Sanfilippo disease. Clin Chim Acta. 1977 Apr 1;76(1):139–147. doi: 10.1016/0009-8981(77)90126-7. [DOI] [PubMed] [Google Scholar]
  21. Yogalingam G., Litjens T., Bielicki J., Crawley A. C., Muller V., Anson D. S., Hopwood J. J. Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease. J Biol Chem. 1996 Nov 1;271(44):27259–27265. doi: 10.1074/jbc.271.44.27259. [DOI] [PubMed] [Google Scholar]
  22. van de Kamp J. J., Niermeijer M. F., von Figura K., Giesberts M. A. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet. 1981 Aug;20(2):152–160. doi: 10.1111/j.1399-0004.1981.tb01821.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES